Bladder cancers associated with gliflozin use: a case/non-case analysis in the World Health Organization's adverse drug reactions database

被引：0
|
作者：
Da Silva, S. [1 ,2 ]
Clarivet, B. [1 ,2 ]
Bres, V. [1 ,2 ]
Hillaire-Buys, D. [1 ,2 ]
Faillie, J. L. [3 ]
机构：
[1] CHU Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France
[2] CHU Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France
[3] Univ Montpellier, Fac Med, Lab Biostat Epidemiol & Publ Hlth, EA 2415, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2 - 048
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [31] Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions
    de Leon, Jose
    Sanz, Emilio J.
    De las Cuevas, Carlos
    SCHIZOPHRENIA BULLETIN, 2020, 46 (01) : 1 - 3
  • [32] Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database
    Lui, Jason L.
    Shaw, Nathan M.
    Abbasi, Behzad
    Hakam, Nizar
    Breyer, Benjamin N.
    ANDROLOGY, 2023, : 1408 - 1417
  • [33] Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database
    Clinard, F
    Sgro, C
    Bardou, M
    Hillon, P
    Dumas, M
    Kreft-Jais, C
    Escousse, A
    Bonithon-Kopp, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (04) : 279 - 283
  • [34] Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: A case/non-case study in the French pharmacovigilance system database
    Moore, N
    KreftJais, C
    Haramburu, F
    Noblet, C
    Andrejak, M
    Ollagnier, M
    Begaud, B
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 513 - 518
  • [35] Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database
    François Clinard
    Catherine Sgro
    Marc Bardou
    Patrick Hillon
    Monique Dumas
    Carmen Kreft-Jais
    André Escousse
    Claire Bonithon-Kopp
    European Journal of Clinical Pharmacology, 2004, 60 : 279 - 283
  • [36] Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis
    Jalles, Cedric
    Lepelley, Marion
    Mouret, Stephane
    Charles, Julie
    Leccia, Marie-Therese
    Trabelsi, Sabiha
    THERAPIE, 2022, 77 (06): : 649 - 656
  • [37] Hearing Impairment Associated with Oral Terbinafine UseA Case Series and Case/Non-Case Analysis in the Netherlands Pharmacovigilance Centre Lareb Database and VigiBase™
    Joep H. G. Scholl
    Eugene P. van Puijenbroek
    Drug Safety, 2012, 35 (8) : 685 - 691
  • [38] Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach
    de Jong, Hilda J. I.
    Saldi, Siti R. F.
    Klungel, Olaf H.
    Vandebriel, Rob J.
    Souverein, Patrick C.
    Meyboom, Ronald H. B.
    Passier, J. L. M.
    van Loveren, Henk
    Tervaert, Jan Willem Cohen
    PLOS ONE, 2012, 7 (07):
  • [39] Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006
    Lapeyre-Mestre, Maryse
    Grolleau, Sabrina
    Montastruc, Jean-Louis
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (02) : 223 - 230
  • [40] Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019
    Montastruc, Jean-Louis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 201 - 208
12345